USPTO serial 90549924
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
L. Jeremy Craft
L. Jeremy Craft CRAFT CHU PLLC1204 HEIGHTS BOULEVARDHOUSTON, TX 77008United States| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment and prevention of alimentary tract and metabolic diseases, blood and blood forming organ diseases, cardiovascular system diseases, dermatological diseases, genito-urinary system and sex hormones diseases, systemic hormonal diseases, systemic infectious diseases, neoplastic or immunomodulatory diseases, musculo-skeletal system diseases, nervous system diseases, parasitological diseases, respiratory system diseases, sensory organs diseases | ACTIVE | — |
| 010 | Inhalers for therapeutic use; Instruments and apparatus provided empty used for the inhalation of pharmaceuticals; Medical apparatus for facilitating the inhalation of pharmaceutical preparations | ACTIVE | — |
| 035 | Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies | ACTIVE | — |
| 040 | Manufacturing services for others in the field of pharmaceuticals | ACTIVE | — |
| 042 | Chemical research services; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Inspection of pharmaceuticals for quality control purposes; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Testing of pharmaceuticals | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 7, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 7, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 14, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 14, 2024 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jun 14, 2024 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jun 14, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 9, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 7, 2023 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Dec 7, 2023 | EXT4 | SOU EXTENSION 4 FILED | — |
| Dec 7, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 23, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 21, 2023 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jun 21, 2023 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jun 21, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 23, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 21, 2022 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Dec 21, 2022 | EXT2 | SOU EXTENSION 2 FILED | — |
| Dec 21, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 2, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 31, 2022 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 31, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 31, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 21, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 26, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 26, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 6, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 21, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 21, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 28, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 2, 2021 | NWAP | NEW APPLICATION ENTERED | — |